We are live on ! Find out more
BIO icon

Bio-Rad Laboratories Class A

203 hedge funds and large institutions have $2.05B invested in Bio-Rad Laboratories Class A in 2013 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 81 increasing their positions, 62 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

336% more call options, than puts

Call options by funds: $1.54M | Put options by funds: $353K

35% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 20

31% more repeat investments, than reductions

Existing positions increased: 81 | Existing positions reduced: 62

3% more funds holding

Funds holding: 198203 (+5)

4% more capital invested

Capital invested by funds: $1.97B → $2.05B (+$77.9M)

0.36% less ownership

Funds ownership: 75.05%74.69% (-0.36%)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

Holders
203
Holders Change
+5
Holders Change %
+2.53%
% of All Funds
6.58%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.1%
New
27
Increased
81
Reduced
62
Closed
20
Calls
$1.54M
Puts
$353K
Net Calls
+$1.19M
Net Calls Change
+$222K
Name Holding Trade Value Shares
Change
Change in
Stake
AG
176
Aperio Group
California
$217K +$217K +1,842 New
CCIA
177
Campbell & Co Investment Adviser
Maryland
$205K -$309K -2,621 -60%
Legal & General Group
178
Legal & General Group
United Kingdom
$186K +$55.7K +472 +42%
GT
179
Glenmede Trust
Pennsylvania
$185K
Credit Agricole
180
Credit Agricole
France
$165K +$165K +1,400 New
STC
181
SEI Trust Company
Pennsylvania
$136K +$137K +1,160 New
Canada Life
182
Canada Life
Manitoba, Canada
$103K +$104K +882 New
TRCT
183
Tower Research Capital (TRC)
New York
$82K +$11K +93 +15%
PAM
184
Paradigm Asset Management
New York
$76.4K -$130K -1,100 -63%
BJ
185
BlackRock Japan
Japan
$61K +$60.9K +516 New
CAL
186
Capital Analysts LLC
Pennsylvania
$49.7K +$49.9K +423 New
RNS
187
Robert N. Shapiro
$49K
HR
188
Howe & Rusling
New York
$39K -$1.89K -16 -5%
FHA
189
First Horizon Advisors
Tennessee
$28K +$24.2K +205 +732%
AW
190
Alpha Windward
Massachusetts
$25K
WT
191
Whittier Trust
California
$24K
PCM
192
Prelude Capital Management
New York
$19K +$18.9K +160 New
WRM
193
Westport Resources Management
Connecticut
$12K +$7.19K +61 +156%
Manulife (Manufacturers Life Insurance)
194
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$12K +$1.48M +12,588 +14%
WCBA
195
Weaver C. Barksdale & Associates
Tennessee
$9K
Envestnet Asset Management
196
Envestnet Asset Management
Illinois
$7K -$2.24K -19 -25%
BBHC
197
Brown Brothers Harriman & Co
New York
$5K -$72.6M -615,339 -100%
GC
198
Globeflex Capital
California
$2K -$519K -4,400 -100%
ECM
199
ETrade Capital Management
Virginia
$2K +$2.12K +18 New
BC
200
Bartlett & Co
Ohio
$2K +$2.48K +21 New

BIO Hedge Fund Activity: Q3 2013 in Review

203 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q3 2013, worth a combined $2.05B — up 3.9% from $1.97B a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new BIO positions and 20 closed out — a net gain of 7 holders — while 81 added to existing stakes and 62 trimmed.

The largest buyer was American Century Companies, opening a new position worth an estimated $29.6M. The largest seller was Brown Brothers Harriman & Co, cutting an estimated $72.6M.

  • 203 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q3 2013, up from 198 in Q2 2013.
  • Funds reported $2.05B of Bio-Rad Laboratories Class A stock for Q3 2013, up 3.9% quarter-over-quarter.
  • 27 funds opened new Bio-Rad Laboratories Class A positions in Q3 2013 and 20 closed out, a net change of +7 holders.
  • The largest Bio-Rad Laboratories Class A buyer in Q3 2013 was American Century Companies, an estimated $29.6M added.
  • The largest Bio-Rad Laboratories Class A seller in Q3 2013 was Brown Brothers Harriman & Co, an estimated $72.6M sold.

Based on aggregated 13F filings for Q3 2013.